Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Article
Cracking the Code: What DTCs Tell Us About Vehicle Repair Trends
Diagnostic scanning has become a critical first—and last—step in the repair process.
Workers' Comp
Blog
At the eye of the storm: An opioid overdose epidemic and a viral pandemic converge
As 2020 opened, a persistent and tragic opioid overdose epidemic was near the front of a list of national concerns in the US.
Workers' Comp
Podcast
Is Your Workplace Safe2Work?
As employers are looking for efficient ways to keep work environments safe from COVID-19, Optis has developed Safe2Work, an app-enabled, web-based
Workers' Comp
Blog
Quality Control in Clinical, Interview with Sharon Riley
Image
Workers' Comp
Blog
Opioid Risk Mitigation: Medication-Assisted Treatment (MAT) and Naloxone
This week in our in-dept
Workers' Comp
News Release
Risk & Insurance: 10 Workers' Comp Podcasts You Really Don't Want to Miss
When it comes to learning about the workers' compensation industry, there is a plethora of resources already at your fingertips.